Where is Nevia Bio located?

Nevia Bio is headquartered in Haifa, Israel.

Who is the current CEO of Nevia Bio?

Inbal ZafirLavie of Nevia Bio. They have also founded 1 company.

Is Nevia Bio a funded company?

Nevia Bio is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of Nevia Bio?

Nevia Bio's latest funding was a $***** Seed round on Aug 29, 2023, with participation from 4 investors. Its primary sector is Disease Self Management. Globally, the Disease Self Management sector has seen $1.21B in funding in 2026 to date.

Where does Nevia Bio rank among its competitors?

Nevia Bio ranks 23rd amongst 148 active competitors, of which 25 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was SquareMind, which secured $18M in Apr, 2026.

Who are the top competitors of Nevia Bio?

Nevia Bio's top competitors include Ovia Health, Hormona and AOA. Among them, SquareMind secured the most recent funding round in April, 2026.

Nevia Bio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Machine learning-enabled platform for early detection of women-related diseases. The platform uses proprietary technologies and machine learning to provide early detection of diseases through vaginal secretions analysis including ovarian cancer. The company offers Nevia 001, Nevia 002, and Nevia 003 being the current programs in development.

Website: www.nevia.bio/
Email ID: *****@nevia.bio

Key Metrics

Founded Year

2023

Location

Haifa, Israel

Stage

Seed

Total Funding

$5M in 2 rounds

Latest Funding Round

Seed, Aug 29, 2023, $*****

Investors

ALIVE & 5 more

Ranked

23^rd among 148 active competitors

Similar Companies

Ovia Health & 168 more

View Nevia Bio's full profile

Nevia Bio has raised a total funding of $5M over 2 rounds. Its latest funding round was a Seed round on Aug 29, 2023 for $*****. 4 investors participated in its latest round. Nevia Bio has 6 institutional investors.

Here is the list of recent funding rounds of Nevia Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 29, 2023	1216834	Seed	7176562	9824602	4915560	7212416

Access funding benchmarks and valuations. Sign up today!

View details of Nevia Bio's funding rounds and investors

The founders of Nevia Bio are Shlomit YehudaiReshef and Inbal ZafirLavie. Inbal ZafirLavie is the CEO of Nevia Bio.

Here are the details of Nevia Bio's key team members:

Shlomit YehudaiReshef: Co-Founder of Nevia Bio.
Inbal ZafirLavie: Co-Founder & CEO of Nevia Bio.

View details of Nevia Bio's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nevia Bio include Ovia Health, Hormona and AOA. Here is the list of Top 10 competitors of Nevia Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ovia Health 2012, Boston (United States), Acquired	Provider of mobile application for women's and family health	$23.5M	Martin Ventures, Zaffre Investments & 13 others	63/100
2nd	Hormona 2019, London (United Kingdom), Seed	Provider of a home-based test for tracking hormone levels	$11M	Supernode Global, Voima Ventures & 9 others	61/100
3rd	AOA 2019, Boston (United States), Series A	Provider of an AI-enabled early detection platform focused on womens health	$40.7M	Good Growth Capital, Y Combinator & 32 others	60/100
4th	Quibim 2015, Valencia (Spain), Series A	Developer of medical imaging software for radiomics and biomarker analysis	$60M	Asabys Partners, Adara & 20 others	58/100
5th	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$3.79M	Hoxton Ventures, LocalGlobe & 5 others	56/100
6th	Aavia 2018, Brooklyn (United States), Series A	Mobile app for tracking hormonal conditions of women	$6.95M	DSM, Dorm Room Fund & 7 others	55/100
7th	Spotitearly 2020, Tel Aviv (Israel), Seed	AI-based cancer detection device for providers	$26.5M	Hanaco Ventures & 5 others	48/100
8th	SquareMind 2019, Paris (France), Seed	Developer of robotic medical equipment for skin cancer detection	$18M	Sonder Capital, Adamed Technology & 7 others	48/100
9th	Astrin 2021, Saint Paul (United States), Series B	AI-empowered 3D holographic imaging platform for early cancer detection	$22.9M	HHS	47/100
10th	Meiyou 2013, Xiamen (China), Series D	Provider of menstrual cycle and pregnancy monitoring software for women	$201M	Matrix Partners China, Cathay Capital & 5 others	46/100
23rd	Nevia Bio 2023, Haifa (Israel), Seed	Machine learning-enabled platform for early detection of women-related diseases	$5M	ALIVE, MassChallenge & 4 others	36/100